Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 3/20 | 0.62 |
| ▸ | MAPT | P10636 | 1/20 | 0.62 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.62 |
| ▸ | LCK | P06239 | 17/20 | 0.61 |
| ▸ | NPC1 | O15118 | 2/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.51 |
| ▸ | MEN1 | O00255 | 1/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6058320 | 0.95 | RAB9A (0.66) | RAB9AMAPTTDP1LCKNPC1 | |
| SCHEMBL6057845 | 0.90 | LCK (0.73) | RAB9ALCKNPC1SMN1; SMN2 | |
| SCHEMBL6058019 | 0.89 | LCK (0.74) | RAB9ALCKNPC1SMN1; SMN2 | |
| SCHEMBL6057586 | 0.85 | NPC1 (0.71) | RAB9AMAPTLCKNPC1SMN1; SMN2 | |
| SCHEMBL6058273 | 0.84 | LCK (0.67) | RAB9ALCKNPC1SMN1; SMN2 | |
| SCHEMBL6057736 | 0.83 | LCK (0.74) | RAB9ALCKNPC1SMN1; SMN2 | |
| SCHEMBL6058277 | 0.82 | LCK (0.71) | LCK | |
| SCHEMBL6058269 | 0.80 | LCK (0.68) | RAB9ALCKNPC1SMN1; SMN2 | |
| SCHEMBL6058238 | 0.80 | LCK (0.70) | RAB9ATDP1LCKNPC1 | |
| SCHEMBL6057796 | 0.79 | LCK (0.78) | LCK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6825355-B2 | FOR THERAPY OF IMMUNOLOGIC DISORDERS SUCH AS TRANSPLANT REJECTION, RHEUMATOID ARTHRITIS. MULTIPLE SCLEROSIS, INFLAMMATORY BOWEL DISEASE, LUPUS, GRAFT VS. HOST DISEASE | BRISTOL-MYERS SQUIBB CO. | 2004-11-30 | — | — | US | claimed |